Strong Success of the Tender Offer Initiated by Alphatec Holdings for Common Shares and Oceanes of EOS imaging
12 Maggio 2021 - 7:00AM
Business Wire
ATEC secures ~89% of EOS common shares and
voting rights as of May 13, 2021
Regulatory News:
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20210511006268/en/
Alphatec Holdings, Inc. (Nasdaq: ATEC) and EOS IMAGING, S.A.
(Paris:EOSI) are pleased to report strong progress in the tender
offer filed by ATEC for the common shares and outstanding
convertible bonds (OCEANEs) of EOS imaging, the results of which
were published on May 10, 2021, by the Autorité des Marchés
Financiers (AMF), with settlement expected to occur on May 13,
2021.
Results of the offer
15,815,971 shares and 2,312,074 "OCEANEs" of EOS IMAGING were
tendered to the offer.
In accordance with the terms of the AMF's general regulations,
ATEC acquired on the market, between March 8 and May 7, 2021,
7,940,090 common shares and 174,061 OCEANEs of EOS IMAGING.
In total, ATEC will hold 23,756,061 EOS IMAGING common shares at
the end of the settlement/ delivery transactions scheduled on May
13, 2021, representing the same number of voting rights, i.e. 89.1%
of the common shares and voting rights of the EOS1.
In addition, ATEC will hold 2,486,135 EOS IMAGING OCEANEs
representing 57.2% of the OCEANEs issued and outstanding.
Reopening of the Offer
The notice of result published on May 10 by the AMF is available
on the AMF website (www.amf-france.org). In accordance with the
requirements of article 232-4 of the AMF's general regulations, the
AMF will re-open the Offer on May 17, 2021, at the same price, i.e.
(i) €2.45 per share and €7.01 per OCEANE (coupon attached and due
on May 31, 2021) or (ii) €6.81 per OCEANE (coupon detached and due
on May 31, 2021), in order to allow holders of EOS imaging who have
not tendered their shares or OCEANEs to do so.
ABOUT EOS imaging
EOS imaging is a global medical device company that designs,
develops and markets innovative, low dose 2D/3D full body and
weight-bearing imaging, rapid 3D modeling of EOS patient X-ray
images, web-based patient-specific surgical planning, and
integration of surgical plan into the operating room that
collectively bridge the entire spectrum of care from imaging to
post-operative assessment capabilities for orthopedic surgery. With
a primary focus on hips, knees, and spine, EOS imaging is targeting
a $2 billion annual market opportunity. EOS imaging has over 400
system installations in more than 40 countries generating more than
1 million patient exams annually. EOS imaging has corporate
locations in U.S., France, Canada, Germany, and Singapore, and has
more than 160 employees. For additional information, please visit
www.eos-imaging.com.
EOS imaging is listed on Compartment C of Euronext Paris
ISIN: FR0011191766 - Ticker: EOSI
ABOUT ALPHATEC HOLDINGS, INC.
Alphatec Holdings, Inc. (ATEC), through its wholly-owned
subsidiaries, Alphatec Spine, Inc. and SafeOp Surgical, Inc., is a
medical device company dedicated to revolutionizing the approach to
spine surgery through clinical distinction. ATEC’s Organic
Innovation Machine is focused on developing new approaches that
integrate seamlessly with the SafeOp Neural InformatiX System to
safely and reproducibly treat spine’s various pathologies and
achieve the goals of spine surgery. ATEC’s vision is to become the
Standard Bearer in Spine. For more information, visit us at
www.atecspine.com.
Alphatec Holdings, Inc. is listed on Nasdaq
ISIN : US02081G2012 - Mnémo : ATEC
1 On the basis of a capital composed of 26,659,946 shares
representing the same number of voting rights, pursuant to the
second paragraph of Article 223-11 of the AMF general
regulations.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210511006268/en/
ATEC Company Contact: J. Todd Koning Chief Financial
Officer investorrelations@atecspine.com
ATEC Investor/Media Contact: Tina Jacobsen, CFA Investor
Relations + 1 (760) 494-6790 investorrelations@atecspine.com
EOS imaging Contact: Valérie Worrall Chief Financial
Officer investors@eos-imaging.com (+33) 1 55 25 60 60
NewCap: EOS Investors Relations Thomas Grojean
eos-imaging@newcap.eu (+33) 1 44 71 94 94
FP2COM EOS Press Relations Florence Portejoie
fportejoie@fp2com.fr (+33) 6 07 76 82 83